Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-041813)

Filing Details

Accession Number:: 0001209191-13-041813
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-08-22 19:40:26
Reporting Period:: 2013-08-20

Filing Date:: 2013-08-22
Accepted Time:: 2013-08-22 19:40:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
876343	Biotime Inc	BTX	Biological Products, (No Disgnostic Substances) (2836)	943127919

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1273885	M Franklin Berger	1301 Harbor Bay Parkway Alameda CA 94502		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares, No Par Value	Acquisiton	2013-08-20	500	$3.71	500	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Shares	Option to Purchase Common Shares	$4.13		2018-06-30	20,000	20,000	Direct
Common Shares	Option to Purchase Common Shares	$4.20		2018-05-12	20,000	20,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2018-06-30	20,000	20,000	Direct
2018-05-12	20,000	20,000	Direct

Footnotes

Will become exercisable in four equal quarterly installments after the date of grant on July 1, 2013 based upon continued service on the board of directors.
Will become exercisable in four equal quarterly installments after the date of grant on May 13, 2013 based upon continued service on the board of directors.